Form 8-K - Current report:
SEC Accession No. 0001104659-26-075211
Filing Date
2026-06-17
Accepted
2026-06-17 16:59:41
Documents
11
Period of Report
2026-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20260617x8k.htm   iXBRL 8-K 46709
  Complete submission text file 0001104659-26-075211.txt   161703

Data Files

Seq Description Document Type Size
2 EX-101.SCH mxct-20260617.xsd EX-101.SCH 2676
3 EX-101.LAB mxct-20260617_lab.xml EX-101.LAB 16575
4 EX-101.PRE mxct-20260617_pre.xml EX-101.PRE 10714
14 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20260617x8k_htm.xml XML 5019
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 261099315
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)